RCT | Liso-cel, a CAR T-Cell therapy, significantly improves outcomes in large B-Cell lymphoma second-line treatment
2 May, 2023 | 13:28h | UTCCommentary: Lisocabtagene Maraleucel Bests Standard Care in LBCL – Cancer Therapy Advisor
Commentary: Lisocabtagene Maraleucel Bests Standard Care in LBCL – Cancer Therapy Advisor